Response by Netuka et al regarding the article 'Evaluation of low-intensity anticoagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study'

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F18%3A00077467" target="_blank" >RIV/00023001:_____/18:00077467 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.jhltonline.org/article/S1053-2498(18)31577-8/pdf" target="_blank" >https://www.jhltonline.org/article/S1053-2498(18)31577-8/pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.healun.2018.07.017" target="_blank" >10.1016/j.healun.2018.07.017</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Response by Netuka et al regarding the article 'Evaluation of low-intensity anticoagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study'

Popis výsledku v původním jazyce

Our investigation seeks to move the field forward toward the position that, when technology advances result in a reduction of thrombotic complications, it makes intuitive sense to begin to decrease the hazards that emanate from excessive anti-coagulation. The pivotal 2-year analysis of the MOMENTUM 3 trial demonstrated that the HeartMate 3 (HM3) left ventricular assist device is associated with absence of pump exchange due to pump thrombosis and a halving of the rate of stroke events. Our ongoing follow-up of cases within the MAGENTUM 1 population suggest preserved stability despite maintenance of low INR in the long-term phase, even beyond 1 year of support.

Název v anglickém jazyce

Response by Netuka et al regarding the article 'Evaluation of low-intensity anticoagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study'

Popis výsledku anglicky

Our investigation seeks to move the field forward toward the position that, when technology advances result in a reduction of thrombotic complications, it makes intuitive sense to begin to decrease the hazards that emanate from excessive anti-coagulation. The pivotal 2-year analysis of the MOMENTUM 3 trial demonstrated that the HeartMate 3 (HM3) left ventricular assist device is associated with absence of pump exchange due to pump thrombosis and a halving of the rate of stroke events. Our ongoing follow-up of cases within the MAGENTUM 1 population suggest preserved stability despite maintenance of low INR in the long-term phase, even beyond 1 year of support.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of heart and lung transplantation

ISSN

1053-2498

e-ISSN

—

Svazek periodika

37

Číslo periodika v rámci svazku

10

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

2

Strana od-do

1279-1280

Kód UT WoS článku

000450568000015

EID výsledku v databázi Scopus

2-s2.0-85054422312